Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of 129Xe MRI With 19F MRI in CF Lung Disease
NCT03482960Phase 1Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- May 2018
- Primary completion
- Apr 2019
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (2 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoint: Volume of unventilated lung area at 1 hour. Started May 2018; status: completed.
Beyond the preview
Go deeper on NCT03482960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03482960.